Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability

Lipid nanoparticles (LNPs) are currently in the spotlight as delivery systems for mRNA therapeutics and have been used in the Pfizer/BioNTech and Moderna COVID-19 vaccines. mRNA-LNP formulations have been indicated to require strict control, including maintenance at fairly low temperatures during th...

詳細記述

書誌詳細

主要な著者:	Mariko Kamiya, Makoto Matsumoto, Kazuma Yamashita, Tatsunori Izumi, Maho Kawaguchi, Shusaku Mizukami, Masako Tsurumaru, Hidefumi Mukai, Shigeru Kawakami
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-10-01
シリーズ:	Pharmaceutics
主題:	mRNA-LNP storage condition stability
オンライン･アクセス:	https://www.mdpi.com/1999-4923/14/11/2357
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!